Structural motifs encoded by individual exons of the human neurokinin-1 receptor gene interact differentially with selective agonists and antagonists

Journal of Neurochemistry

Volumn 67, Issue 3, 1996, Pages 1191-1199

  Tian, Ye ^a   Wu, Lan Hsin ^a   Pu, Yuming ^a   Huang, Che C ^a   Chung, Fu Zon ^a  

^a PFIZER INC   (United States)

Author keywords

Chimeric receptors; Neurokinin; Neurokinin 1; Substance P

Indexed keywords

CHIMERIC PROTEIN; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR; NOLPITANTIUM; RECEPTOR SUBTYPE; SEPTIDE; SUBSTANCE P; SUBSTANCE P DERIVATIVE;

ANIMAL CELL; ARTICLE; CHIMERA; CHO CELL; DRUG RECEPTOR BINDING; EXON; INTRON; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR AFFINITY; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0029801198     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67031191.x     Document Type: Article

References (33)

1. Blount P. and Krause J. E. (1993) Functional nonequivalence of structurally homologous domains of neurokinin-1 and neurokinin-2 type tachykinin receptors. J. Biol. Chem. 268, 16388-16395.
2. Boyd N. D., Kage R., Dumas J. J., Krause J. E., and Leeman S. E. (1996) The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: presence of a disulfide bond. Proc. Natl. Acad. Sci. USA 93, 433-437.
3. Cascieri M. A., Ber E., Fong T. M., Sadowski S., Bansal A., Swain C. J., Seward E., Frances B., and Strader C. D. (1992) Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor. Mol. Pharmacol. 42, 458-463.
4. Chung F. Z., Wu L. H., Vartanian M. A., Watling K. J., Guard S., Woodruff G. N., and Oxender D. L. (1994) The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors. Biochem. Biophys. Res. Commun. 198, 967-972.
5. Elling C. E., Nielsen S. M., and Schwartz T. W. (1995) Conversion of antagonist-binding site to metal-ion site in the tachykinin NK1 receptor. Nature 374, 74-77.
6. Emonds-Alt X., Doutremepuich J. D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J. P., Proietto V., Van Broeck D., Soubrie P., Le Fur G., and Breliere J.-C. (1993) In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur. J. Pharmacol. 250, 403-413.
7. Fong T. M., Huang R. R. C., and Strader C. D. (1992a) Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 267, 25664-25667.
8. Fong T. M., Yu H., Huang R. R. C., and Strader C. D. (1992b) The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. Biochemistry 31, 11806-11811.
9. Fong T. M., Yu H., Cascieri M. A., Underwood D., Swain C. J., and Strader C. D. (1994) Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists. J. Biol. Chem. 269, 14957-14961.
10. Fong T. M., Huang R. R. C., Yu H., Swain C. J., Underwood D., Cascieri M. A., and Strader C. D. (1995) Mutational analysis of neurokinin receptor function. Can. J. Physiol. Pharmacol. 73, 860-865.
11. Francis B. E., Swain C., Sabin V., and Burns H. D. (1994) Radioiodinated L-703,606: a potent, selective antagonist to the human NK1 receptor. Appl. Radiat. Isot. 45, 97-104.
12. Gerard N. P., Eddy R. L. J., Shows T. B., and Gerard C. (1990) The human neurokinin A (substance K) receptor. J. Biol. Chem. 265, 20455-20462.
13. Gether U., Johansen T. E., and Schwartz T. W. (1993a) Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. J. Biol. Chem. 268, 7893-7898.
14. Gether U., Johansen T. E., Snider R. M., Lowe J. A. III, Nakanishi S., and Schwartz T. W. (1993b) Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. Nature 362, 345-348.
15. Gether U., Yokota Y., Emonds-Alt X., Breliere J. C., Lowe J. A. III, Snider R. M., Nakanishi S., and Schwartz T. W. (1993c) Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Proc. Natl. Acad. Sci. USA 90, 6194-6198.
16. Gether U., Emonds-Alt X., Breliere J. C., Fujii T., Hagiwara D., Pradier L., Garret C., Johansen T. E., and Schwartz T. W. (1994) Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor. Mol. Pharmacol. 45, 500-508.
17. Graham A., Hopkins B., Powell S. J., Danks P., and Briggs I. (1991) Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends. Biochem. Biophys. Res. Commun. 177, 8-16.
18. 1 tachykinin receptor in the astrocytoma cell line U 373 MG. J. Neurochem. 60, 868-876.
19. Huang R. R., Yu H., Strader C. D., and Fong T. M. (1994a) Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor. Biochemistry 33, 3007-3013.
20. Huang R. R., Yu H., Strader C. D., and Fong T. M. (1994b) Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions. Mol. Pharmacol. 45, 690-695.
21. Krause J. E., Blount P., and Sachais B. S. (1994) Molecular biology of receptors: structures, expression and regulatory mechanisms, in The Receptors (Bylund D. B., ed), pp. 165-218. University of Nebraska Medical Center, Omaha, Nebraska/Humana Press, Clifton, New Jersey.
22. Li Y. M., Marnerakis M., Stimson E. R., and Maggio J. E. (1995) Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D(1) cells with photolabile agonists. J. Biol. Chem. 270, 1213-1220.
23. Mantyh P. W. (1991) Substance P and the inflammatory and immune response. Ann. NY Acad. Sci. 632, 263-271.
24. Mantyh P. W., Pinnock R. D., Downes C. P., Goedert M., and Hunt S. P. (1984) Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature 309, 795-797.
25. Mauzy C. A., Hwang O., Egloff A. M., Wu L. H., and Chung F. Z. (1992) Cloning, expression, and characterization of a gene encoding the human angiotensin II type 1A receptor. Biochem. Biophys. Res. Commun. 186, 277-284.
26. Pradier L., Menager J., Le Guern J., Bock M. D., Heuillet E., Fardin V., Garret C., Doble A., and Mayaux J. F. (1994) Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol. Pharmacol. 45, 287-293.
27. Regoli D., Boudon A., and Fauchere J. L. (1994) Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46, 551-599.
28. Rosenkilde M. M., Cahir M., Gather U., Hjorth S. A., and Schwartz T. W. (1994) Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J. Biol. Chem. 269, 28160-28164.
29. Sachais B. S., Snider R. M., Lowe J. D., and Krause J. E. (1993) Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J. Biol. Chem. 268, 2319-2323.
30. Samama P., Cotecchia S., Costa T., and Lefkowitz R. J. (1993) A mutation-induced activated state of the beta2-adrenergic receptor. J. Biol. Chem. 268, 4625-4636.
31. Takahashi K., Tanaka A., Hara M., and Nakanishi S. (1992) The primary structure and gene organization of human substance P and neuromedin K receptors. Eur. J. Biochem. 204, 1025-1033.
32. Wu L. H., Vartanian M. A., Oxender D. L., and Chung F. Z. (1994) Identification of methionine 134 and alanine 146 in the second transmembrane segment of the human tachykinin NK3 receptor as residues involved in species-selective binding to SR 48968. Biochem. Biophys. Res. Commun. 198, 961-966.
33. Zoffmann S., Gether U., and Schwartz T. W. (1993) Conserved His (VI-17) of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P. FEBS Lett. 336, 506-510.